Treclin 10 mg/g + 0.25 mg/g Gel
*Company:
Mylan IRE Healthcare LtdStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 01 November 2024
File name
ie-spc-se1134-v031-clean.pdf
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
- Change to section 4.4 - Special warnings and precautions for use
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 6.1 - List of excipients
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 01 November 2024
File name
ie-pl-se1134-v031-clean.pdf
Reasons for updating
- Change to section 2 - excipient warnings
- Change to section 4 - how to report a side effect
- Change to section 6 - what the product contains
- Change to section 6 - date of revision
Updated on 09 July 2019
File name
ie-pl-se1134-v026g-clean.pdf
Reasons for updating
- Change to section 6 - manufacturer
- Change to section 6 - date of revision
Updated on 03 January 2019
File name
ie-pl-se1134-v025rtq-clean.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
- Change to section 5 - how to store or dispose
- Change to section 6 - what the product contains
- Change to section 6 - date of revision
Updated on 03 January 2019
File name
ie-spc-se1134-v025rtq-clean.pdf
Reasons for updating
- Change to section 1 - Name of medicinal product
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.6 - Pregnancy and lactation
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 08 November 2018
File name
ie-pl-se1134-mahtransfer-clean.pdf
Reasons for updating
- New PIL for new product
Updated on 07 November 2018
File name
ie-spc-se1134-mahtransfer-clean.pdf
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 8 - Marketing authorisation number(s)
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 15 July 2016
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 15 July 2016
Reasons for updating
- Change to section 6.6 - Special precautions for disposal and other handling
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
In section 6.6: Special precautions for disposal has changed.
In section 10: The date of revision has been changed.
Updated on 15 July 2016
Reasons for updating
- Change to section 6.6 - Special precautions for disposal and other handling
- Change to section 10 - Date of revision of the text
Free text change information supplied by the pharmaceutical company
In section 6.6: Special precautions for disposal has changed.
In section 10: The date of revision has been changed.
Updated on 06 June 2016
Reasons for updating
- Change to product name
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
date of revision changed
Updated on 06 June 2016
Reasons for updating
- Change to product name
- Change to section 10 - Date of revision of the text
Free text change information supplied by the pharmaceutical company
date of revision changed
Updated on 13 January 2015
Reasons for updating
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
In section 4.5: Information regarding clindamycin and Vitamin K antagonists has been added
In section 4.8: Statement regarding ADR reporting has been added
In section 10: date of revision has changed
Updated on 13 January 2015
Reasons for updating
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Change to section 10 - Date of revision of the text
Free text change information supplied by the pharmaceutical company
In section 4.5: Information regarding clindamycin and Vitamin K antagonists has been added
In section 4.8: Statement regarding ADR reporting has been added
In section 10: date of revision has changed
Updated on 29 July 2014
Reasons for updating
- Change to product name
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Treclinac I % w/w / 0.025 % w/w Gel
to
Treclinac l % w/w / 0.025 % w/w Gel
Updated on 29 July 2014
Reasons for updating
- Change to product name
Free text change information supplied by the pharmaceutical company
Treclinac I % w/w / 0.025 % w/w Gel
to
Treclinac l % w/w / 0.025 % w/w Gel
Updated on 20 June 2014
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Updated on 20 June 2014
Reasons for updating
- New SPC for new product